Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WellellTPE:4106 +0.81%85 FCF Margin % is 6.08% as of Mar. 2026, which is 9% below its 10-year median of 6.69. GuruFocus rates TPE:4106 with a GF Score™ of 85/100 and a GF Value™ of NT$24.05 (Fairly Valued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Wellell ranks better than 76.2% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Wellell's Free Cash Flow for the
three
months ended in Mar. 2026 was NT$35 Mil. Wellell's Revenue for the
three
months ended in Mar. 2026 was NT$583 Mil. Therefore, Wellell's FCF Margin % for the quarter that ended in Mar. 2026 was 6.08%.
The historical rank and industry rank for Wellell's FCF Margin % or its related term are showing as below:
TPE:4106'
s FCF Margin % Range Over the Past 10 Years
Min: -2.54 Med: 6.69 Max: 16
Current: 10.71
During the past 13 years, the highest FCF Margin % of Wellell was 16.00%. The lowest was -2.54%. And the median was 6.69%.
TPE:4106's FCF Margin % is ranked better than 76.2% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.83
vs TPE:4106: 10.71
The historical data trend for Wellell's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4106 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Wellell's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellell FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wellell's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Wellell's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellell (TPE:4106) has a FCF Margin % of 6.08% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Wellell and its competitors. This is near median its historical median of 6.69. According to the industry distribution chart, Wellell ranks #194 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 23.8%.
Is Wellell's FCF Margin % too high?
Wellell's current FCF Margin % of 6.08% is near median its 10-year median of 6.69. Based on the distribution chart, Wellell ranks #194 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Wellell has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wellell's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Wellell ranks #194 out of 815 companies for FCF Margin %. This places Wellell in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Wellell and its competitors. Wellell's current FCF Margin % is 6.08%, which is near median its own 10-year median of 6.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellell stock overvalued right now?
Based on GuruFocus' analysis, Wellell (TPE:4106) is currently considered Fairly Valued. The stock's GF Value™ is NT$24.05, compared to a current price of NT$24.80 — trading 3.1% above its estimated fair value. The current FCF Margin % is 6.08%, which is near median its 10-year median of 6.69. Wellell's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Wellell (TPE:4106), the current FCF Margin % is 6.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wellell (TPE:4106) Overvalued in 2026?
Based on GuruFocus' analysis, Wellell stock appears to be overvalued.
The current stock price of NT$24.80 is trading 3.1% above its estimated GF Value™ of NT$24.05.
GuruFocus considers Wellell to be Fairly Valued.
Key valuation signals for TPE:4106:
FCF Margin %: 6.08% (near median its 10-year median of 6.69)
GF Value™: NT$24.05 vs. price of NT$24.80 (3.1% above fair value)
No single metric tells the full story. See the TPE:4106 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wellell Inc engages in the manufacturing and sale of medical supplies, import and export, as well as agency services. The company provides medical solutions for post-acute care and acute care. Its products include pressure area care, support surfaces, respiratory therapy, compression therapy, and digital health. Geographically, the company operates in Europe, America, and Asia, and the majority of its revenue is generated from Europe.
85GF Score
Get the complete analysis for TPE:4106
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4106 has been successfully added to your 
